Company Name: |
Lynnchem
|
Tel: |
86-(0)29-85992781 17792393971 |
Email: |
info@lynnchem.com |
Products Intro: |
Product Name:leucanicidin CAS:91021-66-8 Purity:>95% by HPLC Package:1mg;5mg
|
Company Name: |
Novachemistry
|
Tel: |
44-20819178-90 02081917890 |
Email: |
info@novachemistry.com |
Products Intro: |
Product Name:Leucanicidin CAS:91021-66-8 Purity:>95% by HPLC Package:1mg;5mg
|
Company Name: |
Shanghai Hongye Biotechnology Co. Ltd
|
Tel: |
400-9205774 |
Email: |
sales@glpbio.cn |
Products Intro: |
Product Name:Leucanicidin CAS:91021-66-8 Purity:>98% Package:1mg;10mg;50mg;100mg;
|
|
| leucanicidin Basic information |
Product Name: | leucanicidin | Synonyms: | leucanicidin;21-O-De(3-carboxy-1-oxo-2-propenyl)-2-demethyl-21-O-(6-deoxy-2-O-methyl-α-L-mannopyranosyl)-2-methoxy-24-methylhygrolidin;Oxacyclohexadeca-3,5,11,13-tetraen-2-one, 16-[(1S,2R,3S)-3-[(2R,4R,5S,6R)-4-[(6-deoxy-2-O-methyl-α-L-mannopyranosyl)oxy]tetrahydro-2-hydroxy-5-methyl-6-(1-methylethyl)-2H-pyran-2-yl]-2-hydroxy-1-methylbutyl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-, (3Z,5E,7R,8S,9S,11E,13E,15S,16R)-;(3Z,5E,7R,8S,9S,11E,13E,15S,16R)-16-[(1S,2R,3S)-3-[(2R,4R,5S,6R)-4-[(6-deoxy-2-O-methyl-α-L-mannopyranosyl)oxy]tetrahydro-2-hydroxy-5-methyl-6-(1-methylethyl)-2H-pyran-2-yl]-2-hydroxy-1-methylbutyl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-oxacyclohexadeca-3,5,11,13-tetraen-2-one | CAS: | 91021-66-8 | MF: | C42H70O13 | MW: | 782.997 | EINECS: | | Product Categories: | | Mol File: | 91021-66-8.mol | |
| leucanicidin Chemical Properties |
Melting point | 130-132 °C | Boiling point | 873.8±65.0 °C(Predicted) | density | 1.18±0.1 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMF: Soluble; DMSO: Soluble; Ethanol: Soluble; Methanol: Soluble | form | A solid | pka | 12.53±0.70(Predicted) |
| leucanicidin Usage And Synthesis |
Uses | Leucanicidin is a potent nematocide and insecticide of the bafilomycin class. | Uses | Leucanicidin is a potent nematocide and insecticide belonging to the bafilomycin class. Lack of access to the pure metabolite has limited its investigation, however structural differences between leucanicidin and the bafilomycins offer scope for investigations into the use of V-ATPases as therapeutic targets. |
| leucanicidin Preparation Products And Raw materials |
|